Balance Sheet Dive: Legend Biotech Corp ADR (LEGN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $40.48 in the prior trading day, Legend Biotech Corp ADR (NASDAQ: LEGN) closed at $40.80, up 0.79%. In other words, the price has increased by $0.79 from its previous closing price. On the day, 1.18 million shares were traded. LEGN stock price reached its highest trading level at $41.5 during the session, while it also had its lowest trading level at $40.24.

Ratios:

Our goal is to gain a better understanding of LEGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.57 and its Current Ratio is at 5.66. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.28.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on June 17, 2024, initiated with a Buy rating and assigned the stock a target price of $88.

On May 24, 2024, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $86 to $73.

On May 23, 2024, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $60.Deutsche Bank initiated its Buy rating on May 23, 2024, with a $60 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEGN now has a Market Capitalization of 7437146624 and an Enterprise Value of 13906641920. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.69 while its Price-to-Book (P/B) ratio in mrq is 6.39. Its current Enterprise Value per Revenue stands at 40.568 whereas that against EBITDA is -32.693.

Stock Price History:

The Beta on a monthly basis for LEGN is 0.09, which has changed by -0.450727 over the last 52 weeks, in comparison to a change of 0.2586832 over the same period for the S&P500. Over the past 52 weeks, LEGN has reached a high of $77.32, while it has fallen to a 52-week low of $38.60. The 50-Day Moving Average of the stock is -10.03%, while the 200-Day Moving Average is calculated to be -29.67%.

Shares Statistics:

The stock has traded on average 1.15M shares per day over the past 3-months and 1145140 shares per day over the last 10 days, according to various share statistics. A total of 181.91M shares are outstanding, with a floating share count of 180.78M. Insiders hold about 0.83% of the company’s shares, while institutions hold 47.11% stake in the company. Shares short for LEGN as of 1715731200 were 12984758 with a Short Ratio of 11.51, compared to 1713139200 on 10983290. Therefore, it implies a Short% of Shares Outstanding of 12984758 and a Short% of Float of 13.69.

Most Popular